Innocoll Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJamese brownInnocoll pharmaceuticals ltdCorporation nasdaqCompany phaseInnocoll pharmaceuticalsDrug administrationExchange commissionSupports single pivotal trialEarnings call todayNew drug applicationEuropean associationFast track designationAlcohol associated hepatitisEnd stage liver diseasePrivate securities litigation reform act

DURECT Corporation To Announce First Quarter 2024 Financial Results And Provide A Business Update

DURECT Corporation To Announce First Quarter 2024 Financial Results And Provide A Business Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesInnocoll pharmaceuticalsExchange commissionDrug administrationCorporation nasdaqInnocoll pharmaceuticals ltdEastern timePacific timeFast trackLooking statementsPrivate securities litigation reform act

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesInnocoll pharmaceuticals ltdExchange commissionInnocoll pharmaceuticalsDrug administrationCorporation nasdaqEastern timeFast trackLooking statementsPrivate securities litigation reform act

DURECT Corporation To Present At The Oppenheimer 34Th Annual Healthcare Life Sciences Conference

DURECT Corporation To Present At The Oppenheimer 34Th Annual Healthcare Life Sciences Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesJamese brownDrug administrationCorporation nasdaqInnocoll pharmaceuticalsExchange commissionHealthcare life sciences conferenceInnocoll pharmaceuticals ltdChief executive officerAnnual healthcare life sciences conferenceFast trackPrivate securities litigation reform actAnnual reportQuarterly report

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

/PRNewswire/ DURECT Corporation (Nasdaq: DRRX) today announced that James E. Brown, President and Chief Executive Officer, will present at the Oppenheimer.

United statesJamese brownHealthcare life sciences conferenceInnocoll pharmaceuticals ltdCorporation nasdaqDrug administrationExchange commissionInnocoll pharmaceuticalsChief executive officerAnnual healthcare life sciences conferenceFast trackLooking statementsPrivate securities litigation reform actAnnual reportQuarterly reportDurect corporation